American Dental Association members are invited to share their expertise and insight on the management of acute dental pain, including the use of nonsteroidal anti-inflammatory drugs and opioids.
A panel of subject matter experts and methodologists from the ADA Science & Research Institute, University of Pennsylvania and University of Pittsburgh are developing a clinical practice guideline on this subject. They are asking the public to review and comment on the guideline’s recommendation statements, which were informed by a systematic review of the best available scientific evidence.
These statements are available to view online at ADA.org/pain.
Comments are due by Dec. 5. The panel and methodologists will review the comments as they further develop the guideline, which will be submitted in 2022 to a peer-reviewed journal for publication.
To learn more or submit comments, visit ADA.org/pain or email the ADA Science & Research Institute at SRI@ADA.org.
